The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: A pilot study

European Respiratory Journal

Volumn 14, Issue 3, 1999, Pages 678-685

  Robinson, M ^a   Daviskas, E ^a   Eberl, S ^a   Baker, J ^a   Chan, H K ^b   Anderson, S D ^a   Bye, P T P ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cystic fibrosis; Hypertonic saline; Mannitol; Mucociliary clearance

Indexed keywords

BRONCHODILATING AGENT; DEFENSIN; MANNITOL;

ADULT; ARTICLE; BRONCHOSPASM; BRONCHUS MUCUS; CLINICAL ARTICLE; COUGHING; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FIBROSIS; MALE; MUCUS SECRETION; NEBULIZATION; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM;

EID: 0032834277     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.14c30.x     Document Type: Article

References (38)

1. Quinton PM. Viscosity versus composition in airway pathology. Editorial. Am J Respir Crit Care Med 1994; 149: 6-7.
2. Matsui H, Grubb BR, Tarran R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998; 95: 1005-1015.
3. Zabner J, Smith JJ, Karp PH, Widdicombe JH, Welsh MJ. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis aiway epithelia in vitro. Mol Cell 1998; 2: 397-403.
4. Robinson M, Regnis JA, Bailey DL, King M, Bautovich GJ, Bye PT. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med 1996; 153: 1503-1509.
5. Robinson M, Hemming AL, Regnis JA, et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997; 52: 900-903.
6. Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Ped Pulmonol 1996; 21: 77-83.
7. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996; 85: 229-236.
8. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997; 88: 553-560.
9. Wills PJ, Chan WM, Hall RL, Cole PJ. Ciliary Transportability of Sputum is Governed by its Osmolality. In: Baum GL, Priel Z, Roth Y, Liron N, Ostfield EJ, eds. Cilia, Mucus and Mucociliary Interactions. New York, Marcel Dekker Inc, 1998; 281-284.
10. Mortensen J, Hansen A, Falk M, Kirketerp I, Groth S. Reduced effect of inhaled B2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis. Chest 1993; 103: 805-811.
11. Marks GB, Yates DH, Sist M, et al. Respiratory sensation during bronchial challenge testing with methacholine, sodium metabisulphite and adenosine monophosphate. Thorax 1996; 51: 793-798.
12. Regnis JA, Robinson M, Bailey DL, et al. Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med 1994; 150: 66-71.
13. Phipps PR, Gonda I, Anderson SD. Apparatus for the control of breathing patterns during aerosol inhalation. J Aerosol Med 1992; 5: 155-169.
14. Bailey DL, Robinson M, Meikle SR, Bye PTP. Simultaneous emission and transmission measurements as an adjunct to dynamic planar gamma camera studies. Eur J Nuc Med 1996; 23: 326-331.
15. Phipps PR, Gonda I, Bailey DL, Borham P, Bautovich G, Anderson SD. Comparisons of planar and tomographic gamma scintigraphy to measure the penetration index of inhaled aerosols. Am Rev Respir Dis 1989; 139: 1516-1523.
16. Bailey DL, Fulton RR, Jackson CB, Hutton BF. Dynamic geometric mean studies using a single headed rotating gamma camera. J Nuc Med 1989; 30: 1865-1869.
17. Altman DG. Practical Statistics for Medical Research, first ed: Chapman & Hall, London, 1991.
18. Daviskas E, Anderson SD, Gonda I, et al. Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. Eur Respir J 1996; 9: 725-732.
19. Rossman CM, Waldes OR, Sampson D, Newhouse MT. Effect of chest physiotherapy on the removal of mucus in patients with cystic fibrosis. Am Rev Respir Dis 1982; 126: 131-135.
20. Pavia D. Lung mucociliary clearance. In: Clarke SW, Pavia D, ed. Aerosols and the Lung. Boston: Butterworths, 1984; pp. 127-155.
21. Daviskas E, Anderson SD, Eberl S, Chan H-K, Bautovich G. Inhalation of dry powder mannitol inproves clearance of mucus in patients with bronchiectasis. Am J Respir Crit Care Med 1999; 159: 1843-1848.
22. Robinson M, Hemming AL, Regnis JA, et al. Improved mucociliary clearance following nebulisation with hypertonic saline in patients with cystic fibrosis. In: Baum GL, Priel Z, Roth Y, Liron N, Ostfield EJ, eds. Cilia, Mucus and Mucociliary Interactions. New York, Marcel Dekker Inc, 1998; 265-280.
23. Winters SL, Yeates DB. Roles of hydration, sodium, and chloride in regulation of canine mucociliary transport system. J Appl Physiol 1997; 83: 1360-1369.
24. Price AM, Webber SE, Widdicombe JG. Osmolality affects ion and water fluxes and secretion in the ferret trachea. J Appl Physiol 1993; 74: 2788-2794.
25. Folkesson HG, Kheradmand F, Matthay MA. The effect of salt water on alveolar epithelial barrier function. Am J Respir Crit Care Med 1994; 150: 1555-1563.
26. Rubin BK, Ramirez O, Zayas G, Finegan B, King M. Respiratory mucus from asymptomatic smokers is better hydrated and more easily cleared by mucociliary action. Am Rev Respir Dis 1992; 145: 545-547.
27. Silber G, Proud D, Warner J, et al. In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis 1988; 137: 606-612.
28. Newton BB, Hall RL. Mucociliary clearance in the guinea pig is increased by ouabain (i.v.) and by hypertonic saline (14.4%) aerosol. In: Baum GL, Priel Z, Roth Y, Liron N, Ostfield EJ, eds. Cilia, Mucus and Mucociliary Interactions. New York, Marcel Dekker Inc, 1998; 285-294.
29. Feng W, Garrett H, Speert DP, King M. Improved clearability of cystic fibrosis sputum with dextran treatement in vitro. Am J Respir Crit Care Med 1998; 157: 710-714.
30. Peatfield AC, Richardson PS, Wells UM. The effect of airflow on mucus secretion into the trachea of the cat. J Physiol 1986; 380: 429-439.
31. Tavakoli S, Levine SJ, Shelhamer JH. Airway Mucus Secretion. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ, eds. Asthma. Philadelphia, Lippencott Raven Publishers, 1997; 843-857.
32. Yankaskas JR, Gatzy JT, Boucher RC. Effects of raised osmolarity on canine tracheal epithelial ion transport function. J Appl Physiol 1987; 62: 2241-2245.
33. Anderson SD, Brannan J, Spring J, et al. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997; 156: 758-765.
34. Mizgerd JP, Kobzik L, Warner AE, Brain JD. Effects of sodium concentration on human neutrophil bactericidal functions. Am J Physiol 1995; 269: L388-393.
35. Hofmann T, Stutts MJ, Ziersch A, et al. Effects of topically delivered benzamil and amiloride on nasal potential difference in cystic fibrosis. Am J Respir Crit Care Med 1998; 157: 1844-1849.
36. Bennett WD, Olivier KN, Zeman KL, Hohnecker KW, Boucher RC, Knowles MR. Effect of Uridine 5́-Triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am J Respir Crit Care Med 1996; 153: 1796-1801.
37. Quinton PM Cystic fibrosis: a disease in electrolyte transport. FASEB J 1990; 4: 2709-2717.
38. Azghani A. Pseudomonas aeruginosa and epithelial permeability: Role of virulence factors elastase and exotoxin A. Am J Respir Cell Mol Biol 1996; 15: 132-140.